Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalised corticosteroid use for COPD exacerbations
2017-001586-24Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prednisolone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University of Oxford. Primary endpoint: Treatment non-response rate. Started Jun 2017; status: completed.
02
Drugs
prednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2017-001586-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001586-24.